170 related articles for article (PubMed ID: 19733918)
1. Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain.
Furrer E; Hulmann V; Urech DM
J Neuroimmunol; 2009 Oct; 215(1-2):65-72. PubMed ID: 19733918
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
3. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
[TBL] [Abstract][Full Text] [Related]
4. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
5. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
6. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Ved PM; Kim K
Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-brain delivery of tacrine.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
[TBL] [Abstract][Full Text] [Related]
10. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
Yu H; Kim K
Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
[TBL] [Abstract][Full Text] [Related]
11. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
Zhao Y; Yue P; Tao T; Chen QH
Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
13. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
Dhuria SV; Hanson LR; Frey WH
J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles.
Wang J; Liu Y; Jiao F; Lao F; Li W; Gu Y; Li Y; Ge C; Zhou G; Li B; Zhao Y; Chai Z; Chen C
Toxicology; 2008 Dec; 254(1-2):82-90. PubMed ID: 18929619
[TBL] [Abstract][Full Text] [Related]
15. Brain penetration and anticonvulsant efficacy of intranasal phenobarbital in rats.
Czapp M; Bankstahl JP; Zibell G; Potschka H
Epilepsia; 2008 Jul; 49(7):1142-50. PubMed ID: 18363707
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the distribution of breviscapine in the brain by different administration routes].
Shi SL; Xu LY; Wu JJ; Li CY; Ge WH; Dai WY
Yao Xue Xue Bao; 2009 May; 44(5):515-8. PubMed ID: 19618729
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of cells to the brain.
Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Buadze M; Geisler J; Klopfer T; Burkhardt U; Proksch B; Verleysdonk S; Ayturan M; Buniatian GH; Gleiter CH; Frey WH
Eur J Cell Biol; 2009 Jun; 88(6):315-24. PubMed ID: 19324456
[TBL] [Abstract][Full Text] [Related]
18. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
Lu W; Jiang W; Chen J; Yin M; Wang Z; Jiang X
Int J Pharm; 2008 Feb; 349(1-2):196-205. PubMed ID: 17904315
[TBL] [Abstract][Full Text] [Related]
19. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.
Li F; Feng J; Cheng Q; Zhu W; Jin Y
Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
Kaur P; Kim K
Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
